NALINI VIJAYVERGIA: Open Payments
NPI 1033683925 · WELLINGTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,156 in 66 payments from 18 companies in 2025. Trend: 2023 $2,185 · 2024 $3,868 · 2025 $2,156
Food & beverage: $2,156
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 19 | $509 |
| AstraZeneca Pharmaceuticals LP | 2 | $316 |
| Novartis Pharmaceuticals Corporation | 13 | $224 |
| Edwards Lifesciences Corporation | 1 | $191 |
| Abbott Laboratories | 2 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $130 |
| Medtronic, Inc. | 1 | $120 |
| Alnylam Pharmaceuticals Inc. | 1 | $110 |
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| CVRx, Inc. | 6 | $84 |
Products named: JARDIANCE, LEQVIO, KONECT RESILIA, ENSITE, Kerendia, AZURE XT DR MRI SURESCAN, AMVUTTRA, Barostim Neo System.
Industry payments across FL — which companies pay providers there.
